临床外科杂志 ›› 2025, Vol. 33 ›› Issue (12): 1277-1282.doi: 10.3969/j.issn.1005-6483.20241482

• 论著 • 上一篇    下一篇

长链非编码RNA 662靶向微小RNA-195-5p/检查点激酶1对甲状腺癌细胞恶性生物学行为的影响

车勇军 连蕾 侯钰 曹海波 李健斐 秦志梅   

  1. 056001 河北邯郸,邯郸市中心医院普外四科(车勇军、侯钰、曹海波),耳鼻咽喉科(连蕾), CT室(李健斐) ,检验科(秦志梅)
  • 出版日期:2025-12-20 发布日期:2025-12-20
  • 基金资助:
    河北省卫生健康委办公室2021年度医学科学研究课题计划(20211344)

Impacts of long non-coding RNA 662 on the malignant biological behavior of thyroid cancer cells by targeting microRNA-195-5p/checkpoint kinase 1

CHE Yongjun,LIAN Lei,HOU Yu,CAO Haibo,LI Jianfei,QIN Zhimei   

  1. Department of General Surgery,Handan Central Hospital, Handan 056001,China
  • Online:2026-01-22 Published:2025-12-20

摘要: 目的 探讨长链非编码RNA 662(LINC00662)靶向微小RNA(miR)-195-5p/检查点激酶1(CHEK1)对甲状腺癌细胞恶性生物学行为的影响。方法 取状态良好的TPC-1细胞,分别转染干扰LINC00662 siRNA(si LINC00662)、阴性对照(si NC),共转染miR-195-5p抑制剂(inhibitor)与si LINC00662、抑制剂阴性对照(inhibitor NC)与si LINC00662,依次记为si NC组、si LINC00662组、si LINC00662+miR-195-5p inhibitor组、si LINC00662+inhibitor NC组,未处理细胞记为对照组。双荧光素酶实验、MTT、Transwell检测分别验证靶向关系、细胞增殖、迁移、侵袭变化;Western blot、qRT-PCR检测TPC-1细胞中增殖蛋白CyclinD1、基质金属蛋白酶(MMP)-2(MMP-2)、CHEK1蛋白表达及基因(LINC00662、miR-195-5p、CHEK1)表达。结果 人甲状腺癌细胞株(BCPAP、BHP5-16、TPC-1和CGTH-W3)LINC00662、CHEK1 mRNA表达较Nthy-ori3-1细胞显著上调,miR-195-5p表达显著下调,差异有统计学意义(P<0.05);miR-195-5p分别与LINC00662、CHEK1存在靶向结合位点;与对照组(100±0.00)%、(163.56±16.36)个、(245.27±24.53)个、1.03±0.11、0.85±0.09、2.14±0.22、2.55±0.26、0.93±0.10、0.33±0.04、si NC组(90.01±9.01)%、(164.35±16.44)个、(247.24±24.73)个、1.07±0.11、0.88±0.09、2.16±0.22、2.57±0.26、0.97±0.10、0.35±0.04相比,si LINC00662组细胞增殖率(43.55±4.36)%、迁移数(73.24±7.33)个、侵袭数(113.27±11.33)个、CyclinD1(0.43±0.05)、MMP-2(0.37±0.04)、LINC00662(1.37±0.14)、CHEK1 mRNA(1.66±0.17)及蛋白(0.55±0.06)表达显著下调,miR-195-5p(0.77±0.08)表达显著上调,差异有统计学意义(P<0.05);抑制miR-195-5p或过表达CHEK1均可逆转干扰LINC00662对甲状腺癌细胞恶性生物学行为的抑制作用。结论 干扰LINC00662可抑制甲状腺癌细胞恶性生物学行为,可能通过调节miR-195-5p/CHEK1实现。

关键词: 长链非编码RNA 662; 甲状腺癌; 微小RNA-195-5p/检查点激酶1; 恶性生物学

Abstract: Objective To investigate the impacts of long non-coding RNA 662(LINC00662) on the malignant biological behavior of thyroid cancer cells by targeting microRNA(miR)-195-5p/checkpoint kinase 1 (CHEK1).Methods Tpc-1 cells in good condition were transfected with interfering LINC00662 siRNA (si LINC00662),negative control (si NC),co-transfected with miR-195-5p inhibitor and si LINC00662,co-transfected with inhibitor NC and si LINC00662,and were successively recorded as si NC group,si LINC00662 group,si LINC00662+miR-195-5p inhibitor group,si LINC00662+inhibitor NC group,and untreated cells were recorded as control group.Double luciferase assay,MTT and Transwell assay were used to verify the targeting relationship,cell proliferation,migration and invasion,respectively.Western blot and qRT-PCR were used to detect the expression of proliferating protein CyclinD1,matrix metalloproteinase (MMP) -2,CHEK1 protein and gene (LINC00662,miR-195-5p,CHEK1) in TPC-1 cells.Results The expression of LINC00662 and CHEK1 mRNA in human thyroid carcinoma cell lines (BCPAP,BHP5-16,TPC-1 and CGTH-W3) was obviously higher than that in Nthy-ori3-1 cells,the expression of miR-195-5p decreased obviously (P<0.05);miR-195-5p had targeted binding sites with LINC00662 and CHEK1,respectively.Compared with the control group[ (100±0.00)%,(163.56±16.36)cells,(245.27±24.53)cells,1.03±0.11,0.85±0.09,2.14±0.22,2.55±0.26,0.93±0.10,0.33±0.04] and the si NC group [(90.01±9.01)%,(164.35±16.44)cells,(247.24±24.73)cells,1.07±0.11,0.88±0.09,2.16±0.22,2.57±0.26,0.97±0.10,0.35±0.04],the si LINC00662 group showed significantly decreased cell proliferation rate [(43.55±4.36)%],migration number [(73.24±7.33) cells],invasion number [(113.27±11.33) cells],CyclinD1 (0.43±0.05),MMP-2 (0.37±0.04),LINC00662 (1.37±0.14),CHEK1 mRNA(1.66±0.17)and protein(0.55±0.06)(P<0.05),while the expression of miR 195 5p (0.77 ± 0.08) was significantly upregulated(P<0.05).Inhibition of miR-195-5p or overexpression of CHEK1 reversed the inhibitory effect of interfering LINC00662 on the malignant biological behavior of thyroid cancer cells.Conclusion Interfering LINC00662 can inhibit the malignant biological behavior of thyroid cancer cells,which may be achieved by regulating miR-195-5p/CHEK1.

Key words: long non-coding RNA 662; thyroid cancer; microRNA-195-5p/checkpoint kinase 1; malignant biology

No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 杨华;李新长;龙成美;等. 公民逝世后器官捐献供肾移植临床分析[J]. 临床外科杂志, 2016, 24(10): 747 .
[2] 胡志伟;汪忠镐;张玉;等. 腹腔镜Toupet胃底折叠术治疗干燥综合征合并严重胃食管反流病两例[J]. 临床外科杂志, 2016, 24(10): 766 .
[3] 李义亮;张成;克力木;等. 完全腹腔镜下远端胃癌根治术的临床体会[J]. 临床外科杂志, 2016, 24(10): 769 .
[4] 胡小平;王志维;邓宏平;等. 改良全主动脉弓置换治疗老年Stanford A型主动脉夹层[J]. 临床外科杂志, 2016, 24(10): 777 .
[5] 宋华;单若冰;张晋绥;等. 产前超声诊断对新生儿消化道梗阻性疾病手术治疗价值的观察[J]. 临床外科杂志, 2016, 24(10): 780 .
[6] 陈绍站;许勇;李婧;等. 防旋股骨近端髓内针与股骨近端解剖锁定钢板治疗转子间骨折的疗效比较[J]. 临床外科杂志, 2016, 24(10): 787 .
[7] 刘琼;江辉. 喉罩在小儿舌系带矫正手术中的应用[J]. 临床外科杂志, 2016, 24(10): 792 .
[8] 涂儒鸿;黄昌明. 腹腔镜胃癌根治术淋巴结清扫技巧[J]. 临床外科杂志, 2016, 24(11): 809 .
[9] 王维君;那光玮;何科基;等. 根治性淋巴结清扫联合脾切除在残胃癌手术中的临床意义探究[J]. 临床外科杂志, 2016, 24(11): 835 .
[10] 许州;陈谦学;李明昌;等. 胶质瘤中miR383与其靶向circ_001634相互调控机制及作用研究[J]. 临床外科杂志, 2016, 24(11): 844 .